The F-D-A recently announced a recall of four different types of intravenous or I-V solutions, some of which were distributed to North State hospitals.
The products were voluntarily recalled by their distributor, Baxter International Incorporated. They contained presence of particulate matter, which the company says could lead to serious health consequences in high risk patients.
Baxter spokesperson John O’Malley said the company has a handful of customers in the North State. He said in an email that all were notified of the recall and directed of the appropriate action to take if they had received any of the affected products. Customer names and locations were not released due to a matter of Baxter’s company policy.
Returned calls from a number of the North State’s major hospitals showed that all had received notification of the recall. Out of those returned calls hospitals who had received recalled products said they had been removed.
A press release from Baxter International Incorporated said the particulate matter was identified as being material from a solution transmission pump. No adverse events or product complaints have been reported. Baxter started notifying customers of the recall in late March. The recall was officially announced Thursday.